Pentapeptide LHRH antagonists
US6297354A · kind A · utility
1Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 1999 |
| Grant date | Oct 2, 2001 |
| Priority date | — |
| Expiry date | Aug 12, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a class of pentapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors, breast and ovaries tumors, cryptorchidism, hirsuitism, gastric motility disorders, dysmenorrhea, and endometriosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.